Drugs / EuPCV15
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04830358 | May → Aug 2020 | pneumococcal infection | EuBiologics Co.,Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EuPCV15 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04830358 ↗ |
| Modality | Vaccine | “15-valent Pneumococcal conjugate vaccine” NCT04830358 ↗ |
| Route | Intramuscular | “will be administered intramuscularly at Day 0.” NCT04830358 ↗ |